A BCMA-specific CAR T Cell Produced with Clinically Scalable Lentiviral and T Cell Manufacturing Processes Has Potent Anti-Multiple Myeloma Activity
Journal for ImmunoTherapy of Cancer(2015)
Key words
Multiple Myeloma,Bortezomib,Chimeric Antigen Receptor,Single Chain Variable Fragment,Murine Xenograft Model
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined